Gemini Therapeutics (GMTX)
NASDAQ:GMTX
US Market
Holding GMTX?
Track your performance easily

Gemini Therapeutics (GMTX) Cash flow

116 Followers

Gemini Therapeutics Cash Flow

GMTX's free cash flow for Q3 2022 was $-4.01M. For the 2022 fiscal year, GMTX's free cash flow was decreased by $-27.04M and operating cash flow was $-4.01M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20
Operating Cash Flow
$ -42.52M$ -59.70M$ -32.71M
Investing Cash Flow
$ 405.00K$ 344.00K$ -22.00K
Financing Cash Flow
$ -6.54M$ 191.48M$ 34.25M
Cash Flow From Discontinued Operation
---
Other Cash Adjustment Inside Changein Cash
---
End Cash Position
$ 466.73M$ 136.95M$ 4.83M
Income Tax Paid Supplemental Data
---
Interest Paid Supplemental Data
$ 177.00K$ 307.00K$ 345.00K
Issuance Of Capital Stock
-$ 0.00$ 20.08M
Issuance Of Debt
-$ 0.00$ 14.00M
Repayment Of Debt
$ -6.67M$ -4.58M$ 0.00
Free Cash Flow
$ -42.52M$ -59.77M$ -32.73M
Domestic Sales
---
Foreign Sales
---
Currency in USD

Gemini Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis